InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: Tekterra post# 25463

Thursday, 03/23/2017 3:32:38 PM

Thursday, March 23, 2017 3:32:38 PM

Post# of 38634
Any further expensive R&D on Regabatin and PODRAS will be paid for by partner as I'm sure you would agree Tek. Dr Odidi's had 8 years to dilute the crap out of IPCI but is as frugal as it comes to diluting. Sure he's a much better scientist than PubCo CEO but a lot of transformation is finally in play this year and therefore a lot can and will change over the next 6 months into the Rexita PDUFA date.

For example securing a potential partner on Rexista and PODRAS can easily still happen by/b4 Rexista PDUFA date...just as a partner can be announced on Glucophage or Regabatin or any of their other remaining ANDA's.

We do know with the pending launches of the remaining FocalinXR strengths by PAR fast approaching and MNK's launch of SerorquelXR in less than 6 weeks IPCI is now well on the road to attaining CFP status...hence strengthening their bargaining power with potential behind the scenes partnership suitors.

There's just so much in play behind the scenes these days that we don't know...but as the chips fall where they may and more clarity is brought forth on next steps of their now burgeoning evolution...it's only a matter of time until the institutional accumulation wave finally arrives.

This should be the turning point year based on everything in motion these days...with many of the unknown questions finally getting answered.



Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y